Processa Pharmaceuticals Inc

Research Processa Pharmaceuticals Inc (PCSA) on Bullrun: market cap USD 5.19M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPCSA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.19M
• Financial periodFY2025
• Net income-USD 13.56M

Valuation Snapshot

latest market cap is USD 5.19M.

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.

Frequently asked questions

What is Processa Pharmaceuticals Inc's market cap?

Processa Pharmaceuticals Inc's market capitalization is USD 5.19M.

What does Processa Pharmaceuticals Inc do?

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States.